HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Fanibunda, Sashaina E ^a   Modi, Deepak N ^a   Gokral, Jyotsna S ^a   Bandivdekar, Atmaram H ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; GLYCOPROTEIN GP 120; MANNAN; MANNOSE RECEPTOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEIN E6; PROTEIN E7; RECEPTOR ANTIBODY; BLOCKING ANTIBODY; CELL SURFACE RECEPTOR; LECTIN; MANNOSE BINDING LECTIN;

ADULT; ARTICLE; BINDING AFFINITY; CELL IMMORTALIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MANNOSE RECEPTOR GENE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 9 GENE; PERMEABILITY BARRIER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR GENE; VAGINA EPITHELIUM; VAGINITIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; ZYMOGRAPHY; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; KINETICS; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT; VAGINA;

ADULT; ANTIBODIES, BLOCKING; CELL LINE; EPITHELIAL CELLS; FEMALE; HIV ENVELOPE PROTEIN GP120; HUMANS; KINETICS; LECTINS, C-TYPE; MANNANS; MANNOSE-BINDING LECTINS; MATRIX METALLOPROTEINASE 9; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; VAGINA; YOUNG ADULT;

EID: 81555205687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028014     Document Type: Article

References (62)

1. UNAIDS report on the global AIDS epidemic 2010. Available: www.unaids.org. Accessed 2011 Jul 24.
2. Hladik F, McElrath MJ, (2008) Setting the stage: host invasion by HIV. Nat Rev Immunol 8: 447-57.
3. Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217-27.
4. Salle B, Brochard P, Bourry O, Mannioui A, Andrieu T, et al. (2010) Infection of Macaques after Vaginal Exposure to Cell-Associated Simian Immunodeficiency Virus. J Infect Dis 202: 337-344.
5. Anderson DJ, (2010) Finally, a Macaque Model for Cell-Associated SIV/HIV Vaginal Transmission. J Infect Dis 202: 333-336.
6. Hladik F, Doncel GF, (2010) Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities. Antiviral Res 88 (Suppl 1): S3-9.
7. Hladik F, Hope TJ, (2009) HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep 6: 20-8.
8. Shattock RJ, Moore JP, (2003) Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1: 25-34.
9. Kell PD, Barton SE, Edmonds DK, Boag FC, (1992) HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J R Soc Med 85: 706-707.
10. Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA, (1992) Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 21: 64-68.
11. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257-70.
12. Miller CJ, Shattock RJ, (2003) Target cells in vaginal HIV transmission. Microbes Infect 5: 59-67.
13. Collins KB, Patterson BK, Naus GJ, Landers DV, Gupta P, (2000) Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 6: 475-9.
14. Hope TJ, (2008) Latest understanding of HIV sexual transmission. Presented at: Microbicides 2008 Conference; New Delhi, India.
15. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, et al. (2000) Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 74: 5577-86.
16. Bobardt MD, Chatterji U, Selvarajah S, Van der Schueren B, David G, et al. (2007) Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 81: 395-405.
17. Fanibunda SE, Velhal SM, Raghavan VP, Bandivdekar AH, (2008) CD4 independent binding of HIV gp120 to mannose receptor on human spermatozoa. J Acquir Immune Defic Syndr 48: 389-97.
18. Trujillo JR, Rogers R, Molina RM, Dangond F, McLane MF, et al. (2007) Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. Proc Natl Acad Sci 104: 5097-102.
19. Liu Y, Liu H, Kim BO, Gattone VH, Li J, et al. (2004) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78: 4120-4133.
20. López-Herrera A, Liu Y, Rugeles MT, He JJ, (2005) HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes. Biochim Biophys Acta 1741: 55-64.
21. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, et al. (2010) Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 6: e1000852.
22. Kaushic C, (2011) HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells. Am J Reprod Immunol 65: 253-60.
23. Fichorova RN, Rheinwald JG, Anderson DJ, (1997) Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod 57: 847-55.
24. Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay MA, Schriver SD, et al. (2011) Increased COX-2 Expression in Human Vaginal Epithelial Cells Exposed to Nonoxynol-9, a Vaginal Contraceptive Microbicide that Failed to Protect Women from HIV-1 Infection. Am J Reprod Immunol 65: 569-77.
25. Trifonova RT, Doncel GF, Fichorova RN, (2009) Polyanionic Microbicides Modify Toll-Like Receptor-Mediated Cervicovaginal Immune Responses. Antimicrob Agents Chemother 53: 1490-1500.
26. Stoddard E, Cannon G, Ni H, Karikó K, Capodici J, et al. (2007) gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission. J Immunol 179: 3126-32.
27. Steele C, Fidel PL, (2002) Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70: 577-583.
28. Fichorova RN, Tucker LD, Anderson DJ, (2001) The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184: 418-428.
29. Kottilil S, Shin K, Jackson JO, Reitano KN, O'Shea MA, et al. (2006) Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J Immunol 176: 1107-14.
30. Missé D, Esteve PO, Renneboog B, Vidal M, Cerutti M, et al. (2001) HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen activated protein kinase signaling pathway. Blood 98: 541-7.
31. Cummins N, Klicpera A, Sainski A, Bren G, Khosla S, et al. (2011) Human immunodeficiency virus envelope protein gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations. PLoS One 6 (9): e24876.
32. Bruno R, Galastri S, Sacchi P, Cima S, Caligiuri A, et al. (2010) gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 59: 513-20.
33. Godbole G, Suman P, Gupta S, Modi D, (2011) Decidualized endometrial stromal cell derived factors promote trophoblast invasion. Fertil Steril 95: 1278-83.
34. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 29: e45.
35. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, et al. (2002) Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360: 971-7.
36. Horbul JE, Schmechel SC, Miller BRL, Rice SA, Southern PJ, (2011) Herpes simplex virus-induced epithelial damage and susceptibility to Human Immunodeficiency Virus Type 1 infection in human cervical organ culture. PLoS ONE 6 (7): e22638.
37. Blaskewicz CD, Pudney J, Anderson DJ, (2011) Structure and Function of Intercellular Junctions in Human Cervical and Vaginal Mucosal Epithelia. Biol Reprod 85: 97-104.
38. Kelly DE, Wood RL, Enders AC, (1984) Bailey's Textbook of Microscopic Anatomy Baltimore Williams and Wilkins pp. 113-159.
39. Lai J, Bernhard OK, Turville SG, Harman AN, Wilkinson J, et al. (2009) Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1. J Biol Chem 284: 11027-38.
40. Roseman DS, Baenziger JU, (2000) Molecular basis of lutropin recognition by the mannose/GalNAc-4-SO4 receptor. Proc Natl Acad Sci 97: 9949-54.
41. Wileman TE, Lennartz MR, Stahl PD, (1986) Identification of the macrophage mannose receptor as a 175-kDa membrane protein. Proc Natl Acad Sci 83: 2501-5.
42. Lennartz MR, Cole FS, Shepherd VL, Wileman TE, Stahl PD, (1987) Isolation and characterization of a mannose-specific endocytosis receptor from human placenta. J Biol Chem 262: 9942-4.
43. Moore L, Crooks T, Porter L, Zhu P, Cayanan S, et al. (2006) Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J Virol 80: 2515-28.
44. Wyatt R, Sodroski J, (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-8.
45. Yang X, Kurteva S, Ren X, Lee S, Sodroski J, (2005) Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J Virol 79: 12132-47.
46. Schneider J, Kaaden O, Copeland TD, Oroszlan S, Hunsmann G, (1986) Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol 67: 2533-8.
47. Pyle SW, Bess JW Jr, Robey WG, Fischinger PJ, Gilden RV, et al. (1987) Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses 3: 387-400.
48. Parren PW, Burton DR, Sattentau QJ, (1997) HIV-1 antibody-debris or virion? Nat Med 3: 366-7.
49. Hicar MD, Chen X, Briney B, Hammonds J, Wang JJ, et al. (2010) Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr 54: 223-35.
50. Crooks ET, Moore PL, Franti M, Cayanan CS, Zhu P, et al. (2007) A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366: 245-262.
51. Lin G, Nara PL, (2007) Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein. Curr HIV Res 5: 514-541.
52. Kuznetsov Y, Victoria J, Robinson W, McPherson A, (2003) Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes. J Virol 77: 11896-909.
53. Chertova E, Bess JW Jr, Crise BJ, Sowder RC II, Schaden TM, et al. (2002) Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 76: 5315-25.
54. O'Brien WA, Mao SH, Cao Y, Moore JP, (1994) Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures. J Virol 68: 5264-9.
55. Gazi U, Martinez-Pomares L, (2009) Influence of the mannose receptor in host immune responses. Immunobiology 214: 554-61.
56. Mastroianni CM, Liuzzi GM, (2007) Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies. Trends Mol Med 13: 449-59.
57. Qiu LB, Zhou Y, Wang Q, Yang LL, Liu HQ, et al. (2011) Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Toxicology 285: 31-8.
58. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA, (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697-709.
59. Reijerkerk A, Kooij G, van der Pol SM, Khazen S, Dijkstra CD, et al. (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. Faseb J 20: 2550-2.
60. Giebel SJ, Menicucci G, McGuire PG, Das A, (2005) Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest 85: 597-607.
61. Navaratna D, McGuire PG, Menicucci G, Das A, (2007) Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56: 2380-7.
62. Wu WB, Huang TF, (2003) Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis. Exp Cell Res 288: 143-57.